• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Genet Evol . Insight into the first multi-epitope-based peptide subunit vaccine against avian influenza A virus (H5N6): An immunoinformatics

tetano

Editor, Senior Moderator
Infect Genet Evol


. 2022 Aug 22;105355.
doi: 10.1016/j.meegid.2022.105355. Online ahead of print.
Insight into the first multi-epitope-based peptide subunit vaccine against avian influenza A virus (H5N6): An immunoinformatics approach


Md Mukthar Mia[SUP] 1 [/SUP], Mahamudul Hasan[SUP] 2 [/SUP], Shakil Ahmed[SUP] 3 [/SUP], Mohammad Nahian Rahman[SUP] 3 [/SUP]



Affiliations

Abstract

The rampant spread of highly pathogenic avian influenza A (H5N6) virus has drawn additional concerns along with ongoing Covid-19 pandemic. Due to its migration-related diffusion, the situation is deteriorating. Without an existing effective therapy and vaccines, it will be baffling to take control measures. In this regard, we propose a revers vaccinology approach for prediction and design of a multi-epitope peptide based vaccine. The induction of humoral and cell-mediated immunity seems to be the paramount concern for a peptide vaccine candidate; thus, antigenic B and d T cell epitopes were screened from the surface, membrane, and envelope proteins of the avian influenza A (H5N6) virus and passed through several immunological filters to determine the best possible one. Following that, the selected prominent, antigenic with immunogenic epitopes and adjuvant were linked to finalize the multi-epitope peptide vaccine by appropriate linkers. For the prediction of an effective binding, molecular docking was carried out between the vaccine and immunological receptors (TLR8). Strong binding affinity and good docking scores clarified the stringency of the vaccines. Furthermore, molecular dynamics simulation was performed within the highest binding affinity complex to observe the stability and minimize the designed vaccine's high mobility region in order to increase its stability. Then, Codon optimization and other physicochemical properties were performed to reveal that the vaccine would be suitable for a higher expression at cloning level and satisfactory thermostability condition. In conclusion, predicting the overall in silico assessment, we anticipated that our designed vaccine would be a plausible prevention against avian influenza A (H5N6) virus.

Keywords: Avian influenza A (H5N6) viruses; Codon optimization; Epitopes; In-silico cloning; Molecular docking; Molecular dynamics simulations.
 
Back
Top Bottom